Aurora Cannabis Inc.
TSX:ACB.TO · Toronto Stock Exchange
+$0.02 today
Vol 0.10M · Avg 0.42M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $112.5M |
| Short-term Investments | $52.2M |
| Receivables | $44.6M |
| Inventory | $175.1M |
| Other Current | $13.1M |
| Total Current Assets | $397.5M |
| PP&E (Net) | $123.7M |
| Goodwill | $26.7M |
| Intangible Assets | $31.4M |
| Long-term Investments | $15.8M |
| Tax Assets | $2.5M |
| Other Non-current | $3.6M |
| Total Non-current Assets | $203.6M |
| Total Assets | $601.1M |
Analysis
Selected assets total $601.1M for Latest. The largest visible component is Inventory at $175.1M, about 29.1% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $112.5M -18.4% | $137.9M +21.6% | $113.4M -62.3% | $300.8M -31.3% | $437.8M | $1.2B | $1.0B | $841.8M |
| Short-term Investments | $52.2M +9324.7% | $554.0K -86.3% | $4.0M | $0 -100.0% | $1.3M | -$1.7B | -$1.6B | $445.6M |
| Net Receivables | $44.6M +5.0% | $42.5M -6.5% | $45.4M +9.8% | $41.3M -12.1% | $47.1M | $668.2M | $533.8M | $399.4M |
| Inventory | $175.1M -26.8% | $239.1M +28.3% | $186.4M +44.7% | $128.8M -7.9% | $139.9M | $652.8M | $641.6M | $328.0M |
| Other Current Assets | $13.1M -77.5% | $58.3M +520.0% | $9.4M +5.4% | $8.9M +36.4% | $6.5M | -$1.7B | $1.5B | $966.4M |
| Total Current Assets | $397.5M -16.9% | $478.3M +12.1% | $426.6M -11.1% | $479.9M -35.6% | $745.1M | $3.6B | $12.5B | $10.5B |
| Property, Plant & Equipment (Net) | $123.7M -53.9% | $268.1M -8.9% | $294.3M -8.9% | $323.0M +38.3% | $233.5M | $575.8M | $1.2B | $1.5B |
| Goodwill | $26.7M -39.3% | $43.9M +1.6% | $43.2M +130.7% | $18.7M | $0 | $1.4B | $925.8M | $466.6M |
| Intangible Assets | $31.4M -30.4% | $45.2M +10.6% | $40.9M -33.5% | $61.4M -13.1% | $70.7M | $1.4B | $568.8M | $860.0M |
| Long-term Investments | $15.8M +200.2% | $5.3M -17.1% | $6.3M -53.9% | $13.7M +1038.8% | $1.2M | $1.2B | $524.0M | -$1.5B |
| Tax Assets | $2.5M -41.7% | $4.2M -72.5% | $15.3M -1.0% | $15.5M | $0 | $364.4M | $1.5B | $1.4B |
| Other Non-current Assets | $3.6M -72.1% | $13.0M +7.9% | $12.0M -14.5% | $14.1M -58.5% | $33.9M | $1.4B | $1.4B | $1.0B |
| Total Non-current Assets | $203.6M -45.6% | $374.3M -9.2% | $412.1M -7.7% | $446.4M +31.6% | $339.2M | $4.7B | -$15.3B | $14.8B |
| Total Assets | $601.1M -29.5% | $852.7M +1.7% | $838.7M -9.5% | $926.3M -14.6% | $1.1B | $14.6B | $13.3B | $11.9B |
| Account Payables | $9.3M -66.3% | $27.6M +35.9% | $20.3M -7.4% | $21.9M +58.3% | $13.9M | $1.2B | $1.3B | -$1.5B |
| Short-term Debt | $5.7M -73.4% | $21.5M -62.4% | $57.2M -61.2% | $147.6M +347.1% | $33.0M | $1.2B | -$1.6B | -$1.6B |
| Tax Payables | $0 -100.0% | $10.1M +149.9% | $4.0M +2413.7% | $161.0K -85.7% | $1.1M | $708.8M | $574.4M | -$1.5B |
| Deferred Revenue | $1.3M +18.2% | $1.1M -36.3% | $1.7M -3.0% | $1.7M -54.8% | $3.9M | $340.6M | -$1.6B | $374.2M |
| Other Current Liabilities | $44.9M +2560.3% | $1.7M -93.3% | $25.1M -49.0% | $49.1M -39.1% | $80.7M | $650.0M | $1.1B | $1.5B |
| Total Current Liabilities | $66.9M -39.6% | $110.9M -11.0% | $124.6M -48.6% | $242.3M +66.8% | $145.2M | $12.8B | $6.0B | $10.1B |
| Long-term Debt | $0 -100.0% | $40.2M -15.5% | $47.6M +31.6% | $36.2M -84.7% | $236.5M | $483.4M | $1.3B | $438.6M |
| Deferred Tax Liabilities | $0 -100.0% | $1.9M -88.3% | $16.2M -3.3% | $16.7M +485.1% | $2.9M | $1.2B | $746.6M | $612.2M |
| Deferred Revenue (Non-current) | $0 | $0 -100.0% | $2.3M -94.7% | $43.8M +17.4% | $37.3M | $1.0B | -$1.6B | $715.8M |
| Other Non-current Liabilities | $4.2M -92.2% | $53.6M +16.3% | $46.1M -34.3% | $70.2M +54718.8% | $128.0K | $1.2B | $489.0M | $1.1B |
| Total Non-current Liabilities | $22.3M -83.2% | $133.2M +18.7% | $112.2M -32.8% | $166.9M -39.7% | $276.8M | $11.3B | $3.9B | $7.5B |
| Total Liabilities | $89.3M -63.4% | $244.1M +3.1% | $236.8M -42.1% | $409.2M -3.0% | $422.0M | $8.8B | $14.7B | $3.7B |
| Common Stock | $7.0B +0.2% | $7.0B +0.3% | $7.0B +1.9% | $6.8B +1.3% | $6.8B | $785.8M | $651.4M | $517.0M |
| Retained Earnings | -$6.4B -1.2% | -$6.4B +0.0% | -$6.4B -1.1% | -$6.3B -4.3% | -$6.0B | $1.0B | -$1.6B | $519.8M |
| Accumulated OCI | -$53.5M +4.9% | -$56.2M -28.7% | -$43.7M +25.1% | -$58.3M -7.0% | -$54.5M | -$1.6B | $393.8M | $550.6M |
| Other Stockholders Equity | $7.0B | $0 | $0 | $0 | $0 | $486.2M | $351.8M | -$1.6B |
| Minority Interest | $0 -100.0% | $41.4M -1.6% | $42.1M +35.5% | $31.1M +5978.5% | $511.0K | $853.0M | $1.4B | $337.8M |
| Total Equity | $511.8M -15.9% | $608.6M +1.1% | $601.9M +16.4% | $517.1M -21.9% | $662.4M | $10.4B | $9.1B | $7.7B |
| Total Debt | $23.9M -77.2% | $104.6M -0.2% | $104.8M -53.9% | $227.5M -15.6% | $269.5M | $735.4M | $724.2M | $410.6M |
| Net Debt | -$88.6M -165.8% | -$33.3M -285.5% | -$8.6M +88.2% | -$73.3M +56.4% | -$168.3M | -$1.7B | $389.6M | $501.6M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Cresco Labs Inc.
CL.CN
$410.90M
Cipher Pharmaceuticals Inc.
TSX:CPH.TO
$408.80M
Spectral Medical Inc.
TSX:EDT.TO
$399.05M
Fennec Pharmaceuticals Inc.
TSX:FRX.TO
$360.97M
High Tide Inc.
HITI.V
$289.09M
TerrAscend Corp.
TSX:TSND.TO
$283.25M
Auxly Cannabis Group Inc.
TSX:XLY.TO
$250.54M
Canopy Growth Corporation
TSX:WEED.TO
$247.17M
OrganiGram Holdings Inc.
TSX:OGI.TO
$187.64M
Jushi Holdings Inc.
JUSH.CN
$133.80M
SEC Filings
Recent regulatory filings
No filings found.
How much cash does ACB.TO have?
Aurora Cannabis Inc. (ACB.TO) reported $112.48M in cash and equivalents in fiscal 2026.
How much debt does ACB.TO carry?
Aurora Cannabis Inc. (ACB.TO) reported $23.86M of total debt, with net debt of -$88,622,000.00.
Explore More
Continue the stock analysis
Jump to another research area for this company.